GSI 704 (Truvada 133 mg / 200 mg)
Generic Name: emtricitabine/tenofovir
Pill with imprint GSI 704 is Blue, Rectangle and has been identified as Truvada 133 mg / 200 mg. It is supplied by Gilead Sciences, Inc..
Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 133 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 704
Truvada
- Generic Name
- emtricitabine/tenofovir
- Imprint
- GSI 704
- Strength
- 133 mg / 200 mg
- Color
- Blue
- Size
- 16.00 mm
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-0704
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
water,
FD&C Blue No. 2,
aluminum oxide,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about Truvada (emtricitabine / tenofovir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 30 Reviews
- Generic Availability
- Drug class: antiviral combinations
- FDA Approval History
Consumer resources
- Other brands
- AccessPak for HIV PEP Basic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.